tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

Avacta’s AVA6000 Shows Promise in Phase 1 Trial
Company AnnouncementsAvacta’s AVA6000 Shows Promise in Phase 1 Trial
4d ago
Avacta Reports Updated Phase 1 Clinical Data of AVA6000 at the European Society for Medical Oncology (ESMO) Congress Demonstrating Multiple Ongoing, Durable Responses in Solid Tumors
PremiumPress Releases
Avacta Reports Updated Phase 1 Clinical Data of AVA6000 at the European Society for Medical Oncology (ESMO) Congress Demonstrating Multiple Ongoing, Durable Responses in Solid Tumors
6d ago
Avacta Group Announces Upcoming Interim Results
PremiumCompany Announcements
Avacta Group Announces Upcoming Interim Results
8d ago
Avacta Reveals Promising AVA6000 Trial Data at ESMO
PremiumCompany Announcements
Avacta Reveals Promising AVA6000 Trial Data at ESMO
11d ago
Avacta to present updated clinical data on AVA6000 at the European Society for Medical Oncology (ESMO) Congress
PremiumPress Releases
Avacta to present updated clinical data on AVA6000 at the European Society for Medical Oncology (ESMO) Congress
11d ago
Avacta Group Announces Executive Share Options
PremiumCompany AnnouncementsAvacta Group Announces Executive Share Options
18d ago
Avacta Settles Bond Payment in Cash, On Track for 2024 Goals
Premium
Company Announcements
Avacta Settles Bond Payment in Cash, On Track for 2024 Goals
2M ago
Avacta Announces the Appointment of Darlene Deptula-Hicks as Non-Executive Director of the Board of Directors
Premium
Press Releases
Avacta Announces the Appointment of Darlene Deptula-Hicks as Non-Executive Director of the Board of Directors
2M ago
Avacta Group’s AGM Success and Clinical Advances
PremiumCompany Announcements
Avacta Group’s AGM Success and Clinical Advances
3M ago
Avacta Advances Cancer Drug Trial, Strengthens Board
PremiumCompany Announcements
Avacta Advances Cancer Drug Trial, Strengthens Board
3M ago
Avacta Group Appoints New Chairman, Eyes Growth
PremiumCompany Announcements
Avacta Group Appoints New Chairman, Eyes Growth
3M ago
Avacta Engages Peel Hunt as New Adviser
PremiumCompany Announcements
Avacta Engages Peel Hunt as New Adviser
3M ago
Avacta Group Announces AGM and Yearly Report
PremiumCompany AnnouncementsAvacta Group Announces AGM and Yearly Report
4M ago
Avacta Advances Oncology Program with AVA6000 Trial
Premium
Company Announcements
Avacta Advances Oncology Program with AVA6000 Trial
4M ago
Avacta Group Advances with Strong 2023 Performance
Premium
Company Announcements
Avacta Group Advances with Strong 2023 Performance
5M ago
Avacta Appoints New CEO to Advance Cancer Treatments
PremiumCompany Announcements
Avacta Appoints New CEO to Advance Cancer Treatments
5M ago
Avacta Group Announces New Share Listing
PremiumCompany Announcements
Avacta Group Announces New Share Listing
5M ago
Avacta Group Announces Upcoming Financial Results
PremiumCompany Announcements
Avacta Group Announces Upcoming Financial Results
5M ago
Avacta Group Issues Shares to Settle Debt
PremiumCompany Announcements
Avacta Group Issues Shares to Settle Debt
5M ago
Avacta Group – AVA6000 Abstract Release by AACR and Full Presentation Update
PremiumPress ReleasesAvacta Group – AVA6000 Abstract Release by AACR and Full Presentation Update
6M ago
Updated Results from Single-Agent Phase 1 Clinical Trial of Peptide Drug Conjugate, AVA6000 to be Presented in a Poster at the American Association of Cancer Research (AACR) Annual Meeting on April 9, 2024
Premium
Press Releases
Updated Results from Single-Agent Phase 1 Clinical Trial of Peptide Drug Conjugate, AVA6000 to be Presented in a Poster at the American Association of Cancer Research (AACR) Annual Meeting on April 9, 2024
7M ago
Appointment of Chief Business Officer
Premium
Press Releases
Appointment of Chief Business Officer
9M ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >